Table 1.

Condensed EORTC 2007 guidelines for erythropoiesisstimulating agents treatment

Hb initiation level	9–11 g/dl
Early intervention, Hb < 12	Yes, with falling Hb and further chemotherapy planned
Prophylactic treatment	No
Additional oral iron	No
Additional Iv iron	Yes
Elderly patients	Treatment as younger
Dose escalation	No
Dosing	Epo alfa and beta QW, darbepoetin QW or Q 3W
Target Hb level	12–13 g/dl
Goal of therapy	QoL improvement and transfusion prevention
Higher starting dose	No

Abbreviations: QoL, quality of life.